Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 79
Filtrar
Mais filtros

Base de dados
País/Região como assunto
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Clin Transl Radiat Oncol ; 40: 100593, 2023 May.
Artigo em Inglês | MEDLINE | ID: mdl-36875870

RESUMO

Purpose/Objectives: To analyze the long term efficacy and safety of an ultra-hypofractionated (UHF) radiation therapy prostate treatment regimen with HDR brachytherapy boost (BB) and compare it to moderate-hypofractionated regimens (MHF). Materials/Methods: In this single arm, prospective monocentric study, 28 patients with intermediate risk prostate cancer were recruited in an experimental treatment arm of 25 Gy in 5 fractions plus a 15 Gy HDR BB. They were then compared to two historical control groups, treated with either 36 Gy in 12 fractions or 37.5 Gy in 15 fractions with a similar HDR BB. The control groups included 151 and 311 patients respectively. Patient outcomes were reported using the International Prostate Symptom Score (IPSS) and Expanded Prostate Index Composite (EPIC-26) questionnaires at baseline and at each follow-up visit. Results: Median follow-up for the experimental arm was 48.5 months compared to 47 months and 60 months compared to the 36/12 and 37,5/15 groups respectively. The IPSS and EPIC scores did not demonstrate any significant differences in the gastrointestinal or genitourinary domains between the three groups over time. No biochemical recurrence occurred in the UHF arm as defined by the Phoenix criterion. Conclusion: The UHF treatment scheme with HDR BB seems equivalent to standard treatment arms in terms of toxicities and local control. Randomized control trials with larger cohorts are ongoing and needed to further confirm our findings.

2.
J Neuroradiol ; 37(1): 68-71, 2010 Mar.
Artigo em Francês | MEDLINE | ID: mdl-19665792

RESUMO

We report an atypical case of cerebral toxoplasmosis (CT) in a 70-year-old woman with a history of breast cancer. Contrast-enhanced computed tomography revealed a single ring-enhancing lesion in the pons with perifocal oedema and mass effect. Toxoplasma encephalitis was suggested by means of diffusion weighted imaging, MR perfusion and MR spectroscopy, leading to the discovery of HIV infection. The patient was put on antitoxoplasma therapy. Subsequent clinical and radiological improvements confirmed the diagnosis.


Assuntos
Encéfalo/patologia , Angiografia por Ressonância Magnética/métodos , Espectroscopia de Ressonância Magnética/métodos , Toxoplasmose Cerebral/diagnóstico , Idoso , Feminino , Humanos
3.
ACS Appl Mater Interfaces ; 12(5): 6716-6726, 2020 Feb 05.
Artigo em Inglês | MEDLINE | ID: mdl-31922715

RESUMO

A novel extrinsic method for the measurement of particle surface distribution in a carbon black-filled elastomer via nanoindentation is developed. This method is based on the measurement of the contact stiffness obtained from the continuous stiffness measurement mode. The proposed tip-particle model is held by two main hypotheses: the particles do not deform significantly during indentation so that only the elastomer matrix elastically deforms; particles are physically bounded with the surrounding matrix. Therefore, when the tip comes in contact with a particle, the latter becomes a hard extension of the tip, able to deform the elastomer matrix. Finally, the evolution of the measured contact stiffness is directly related to the increase of the contact area between the tip-particles set and the elastomer matrix. The proposed model is validated through a numerical and an experimental study. Moreover, an evaluation of the measurements bias allows to correct the particle surface distribution. A good agreement is found between the distribution measured from transmission electron microscopy observations and nanoindentation measurements.

4.
J Cell Biol ; 136(1): 29-43, 1997 Jan 13.
Artigo em Inglês | MEDLINE | ID: mdl-9008701

RESUMO

Here we report that DNA decatenation is not a physical requirement for the formation of mammalian chromosomes containing a two-armed chromosome scaffold. 2-aminopurine override of G2 arrest imposed by VM-26 or ICRF-193, which inhibit topoisomerase II (topo II)-dependent DNA decatenation, results in the activation of p34cdc2 kinase and entry into mitosis. After override of a VM-26-dependent checkpoint, morphologically normal compact chromosomes form with paired axial cores containing topo II and ScII. Despite its capacity to form chromosomes of normal appearance, the chromatin remains covalently complexed with topo II at continuous levels during G2 arrest with VM-26. Override of an ICRF-193 block, which inhibits topo II-dependent decatenation at an earlier step than VM-26, also generates chromosomes with two distinct, but elongated, parallel arms containing topo II and ScII. These data demonstrate that DNA decatenation is required to pass a G2 checkpoint, but not to restructure chromatin for chromosome formation. We propose that the chromosome core structure is templated during interphase, before DNA decatenation, and that condensation of the two-armed chromosome scaffold can therefore occur independently of the formation of two intact and separate DNA helices.


Assuntos
Proteínas Aviárias , Cromossomos/metabolismo , DNA/metabolismo , Fase G2/fisiologia , 2-Aminopurina/farmacologia , Animais , Antimetabólitos/farmacologia , Células CHO , Proteínas de Ciclo Celular , Linhagem Celular , Cromatina/metabolismo , Cricetinae , DNA Topoisomerases Tipo II/fisiologia , Proteínas de Ligação a DNA/metabolismo , Dicetopiperazinas , Inibidores Enzimáticos/farmacologia , Rim , Mitose , Modelos Genéticos , Proteínas Nucleares/metabolismo , Piperazinas/farmacologia , Teniposídeo/farmacologia , Inibidores da Topoisomerase II
5.
J Cell Biol ; 151(7): 1575-82, 2000 Dec 25.
Artigo em Inglês | MEDLINE | ID: mdl-11134084

RESUMO

Survivin, a dimeric baculovirus inhibitor of apoptosis repeat (BIR) motif protein that is principally expressed in G2 and mitosis, has been associated with protection against apoptosis of cells that exit mitosis aberrantly. Mammalian survivin has been reported to associate with centrosomes and with the mitotic spindle. We have expressed a human hemagglutinin-tagged survivin plasmid to determine its localization, and find instead that it clearly acts as a passenger protein. In HeLa cells, survivin first associates with the kinetochores, and then translocates to the spindle midzone during anaphase and, finally, to the midbody during cell cleavage. Its localization is similar to that of TD-60, a known passenger protein. Both a point mutation in the baculovirus IAP repeat motif (C84A) and a COOH-terminal deletion mutant (Delta106) of survivin fail to localize to either kinetochores or midbodies, but neither interferes with cell cleavage. The interphase localization of survivin is cell cycle regulated since in permanently transfected NIH3T3 cells it is excluded from the nuclei until G2, where it localizes with centromeres. Survivin remains associated with mitotic kinetochores when microtubule assembly is disrupted and its localization is thus independent of microtubules. We conclude that human survivin is positioned to have an important function in the mechanism of cell cleavage.


Assuntos
Cinetocoros/metabolismo , Proteínas Associadas aos Microtúbulos , Proteínas/metabolismo , Células 3T3 , Motivos de Aminoácidos , Substituição de Aminoácidos/genética , Animais , Divisão Celular , Imunofluorescência , Células HeLa , Humanos , Proteínas Inibidoras de Apoptose , Camundongos , Mutação/genética , Proteínas de Neoplasias , Ligação Proteica , Transporte Proteico , Proteínas/química , Proteínas/genética , Proteínas Recombinantes de Fusão/química , Proteínas Recombinantes de Fusão/metabolismo , Fuso Acromático/metabolismo , Survivina , Dedos de Zinco
6.
J Cell Biol ; 135(3): 689-700, 1996 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-8909543

RESUMO

Taxol (paclitaxel) induces a microtubule hyperassembled state, and effectively blocks cells in mitosis. Here we report that Taxol also induces a stable late-G1 block in nontransformed REF-52 and WI-38 mammalian fibroblast cells, but not in T antigen-transformed cells of the same parental lineage. G1 arrest is characterized by partially dephosphorylated pRb, and inactive cdk2 kinase. Nontransformed cells recover normally from Taxol arrest. In contrast, T antigen transformed cells continue inappropriately past both G1 and G2-M in the presence of Taxol, and undergo a rapid death upon release. These results demonstrate a microtubule sensitive step in G1 regulation of nontransformed fibroblast cells. Also, Taxol selectively induces death of transformed cells, possibly because they slip the Taxol-dependent G1 arrest, as well as G2/M arrest, which are both specific to nontransformed cells.


Assuntos
Antineoplásicos Fitogênicos/farmacologia , Quinases relacionadas a CDC2 e CDC28 , Proteínas de Ciclo Celular , Fibroblastos/citologia , Fase G1/efeitos dos fármacos , Paclitaxel/farmacologia , Proteínas Proto-Oncogênicas , Proteínas Supressoras de Tumor , Animais , Antígenos Transformantes de Poliomavirus/fisiologia , Apoptose/efeitos dos fármacos , Linhagem Celular , Linhagem Celular Transformada , Quinase 2 Dependente de Ciclina , Quinase 4 Dependente de Ciclina , Inibidor de Quinase Dependente de Ciclina p21 , Inibidor de Quinase Dependente de Ciclina p27 , Quinases Ciclina-Dependentes/análise , Quinases Ciclina-Dependentes/antagonistas & inibidores , Ciclinas/análise , Inibidores Enzimáticos , Humanos , Hidroxiureia/farmacologia , Proteínas Associadas aos Microtúbulos/análise , Microtúbulos/efeitos dos fármacos , Nocodazol/farmacologia , Proteínas Serina-Treonina Quinases/análise , Ratos , Proteína do Retinoblastoma/análise , Vírus 40 dos Símios/imunologia
7.
J Cell Biol ; 141(5): 1207-15, 1998 Jun 01.
Artigo em Inglês | MEDLINE | ID: mdl-9606212

RESUMO

Protein phosphatase-1 (PP-1) is involved in the regulation of numerous metabolic processes in mammalian cells. The major isoforms of PP-1, alpha, gamma1, and delta, have nearly identical catalytic domains, but they vary in sequence at their extreme NH2 and COOH termini. With specific antibodies raised against the unique COOH-terminal sequence of each isoform, we find that the three PP-1 isoforms are each expressed in all mammalian cells tested, but that they localize within these cells in a strikingly distinct and characteristic manner. Each isoform is present both within the cytoplasm and in the nucleus during interphase. Within the nucleus, PP-1 alpha associates with the nuclear matrix, PP-1 gamma1 concentrates in nucleoli in association with RNA, and PP-1 delta localizes to nonnucleolar whole chromatin. During mitosis, PP-1 alpha is localized to the centrosome, PP-1 gamma1 is associated with microtubules of the mitotic spindle, and PP-1 delta strongly associates with chromosomes. We conclude that PP-1 isoforms are targeted to strikingly distinct and independent sites in the cell, permitting unique and independent roles for each of the isoforms in regulating discrete cellular processes.


Assuntos
Isoenzimas/análise , Mitose , Fosfoproteínas Fosfatases/análise , Sequência de Aminoácidos , Especificidade de Anticorpos , Células HeLa , Humanos , Interfase , Isoenzimas/imunologia , Dados de Sequência Molecular , Fosfoproteínas Fosfatases/imunologia , Proteína Fosfatase 1 , Frações Subcelulares
8.
Ann Biol Clin (Paris) ; 66(1): 100-4, 2008.
Artigo em Francês | MEDLINE | ID: mdl-18227012

RESUMO

Thrombocytopenia frequently occurs in laboratory practice. The present work illustrates, through the presentation of a case report of Wiskott-Aldrich syndrome, the difficulties encountered to identify and characterize thrombocytopenia. The clinicobiological validation of a low platelet count involves both the biologist, who must assume the validation of numeration while mentioning the morphological characteristics of the platelets and other blood cells, as well as the physician who has to interpret these data according to the clinical context.


Assuntos
Contagem de Plaquetas , Trombocitopenia/etiologia , Síndrome de Wiskott-Aldrich/diagnóstico , Plaquetas/patologia , Diagnóstico Diferencial , Humanos , Lactente , Masculino , Trombocitopenia/sangue , Trombocitopenia/patologia , Síndrome de Wiskott-Aldrich/sangue , Síndrome de Wiskott-Aldrich/patologia
9.
J Chir (Paris) ; 145(5): 454-8, 2008.
Artigo em Francês | MEDLINE | ID: mdl-19106866

RESUMO

Over the past two decades, dramatic improvements in the treatment of children with Non-Hodgkin's Lymphoma have led to cure rates close to 90%, even in advanced-stage disease. The most frequent localization is abdominal, where Burkitt or Burkitt-like subtypes are predominant. Initial management often occurs in the setting of a urgent surgical intervention where multiple complications may gravely threaten prognosis within days or even hours. The SFCE Lymphoma Committee's guidelines for optimal management include: 1) The diagnosis of lymphoma should be systematically evoked whenever the clinical context is not consistent with idiopathic intussusception, particularly in children over the age of 3 or when clinical and/or ultrasound findings are not typical; 2) Limited bowel resection should be performed only if it allows complete tumor removal and is technically simple without extensive dissection or risk of major complications; 3) If surgical resection is likely to be difficult, risky, or incomplete, surgery should be limited to sampling of peritoneal fluid and tumor; 4) In all cases, adequate tissue should be obtained and sent to the pathology department in appropriate media Analysis of tumor material may require, in addition to histology and cytology, immunophenotyping, cytogenetics, and molecular biology studies in order to arrive at an accurate diagnosis and prognosis and to guide treatment choices.


Assuntos
Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico , Neoplasias Intestinais/tratamento farmacológico , Neoplasias Intestinais/cirurgia , Linfoma não Hodgkin/tratamento farmacológico , Linfoma não Hodgkin/cirurgia , Guias de Prática Clínica como Assunto , Dor Abdominal/etiologia , Quimioterapia Adjuvante , Criança , Medicina Baseada em Evidências , França , Humanos , Neoplasias Intestinais/complicações , Neoplasias Intestinais/diagnóstico , Linfoma não Hodgkin/complicações , Linfoma não Hodgkin/diagnóstico , Sociedades Médicas , Resultado do Tratamento
10.
J Chir (Paris) ; 145(5): 454-8, 2008 Oct.
Artigo em Francês | MEDLINE | ID: mdl-22793520

RESUMO

A. Delarue, C. Bergeron, F. Mechinaud-Lacroix, C. Coze, M. Raphael, C. Patte, pour le « Comité Lymphome ¼ de la SFCE Over the past two decades, dramatic improvements in the treatment of children with Non-Hodgkin's Lymphoma have led to cure rates close to 90%, even in advanced-stage disease. The most frequent localization is abdominal, where Burkitt or Burkitt-like subtypes are predominant. Initial management often occurs in the setting of a urgent surgical intervention where multiple complications may gravely threaten prognosis within days or even hours. The SFCE Lymphoma Committee's guidelines for optimal management include: 1) The diagnosis of lymphoma should be systematically evoked whenever the clinical context is not consistent with idiopathic intussusception, particularly in children over the age of 3 or when clinical and/or ultrasound findings are not typical; 2) Limited bowel resection should be performed only if it allows complete tumor removal and is technically simple without extensive dissection or risk of major complications; 3) If surgical resection is likely to be difficult, risky, or incomplete, surgery should be limited to sampling of peritoneal fluid and tumor; 4) In all cases, adequate tissue should be obtained and sent to the pathology department in appropriate media Analysis of tumor material may require, in addition to histology and cytology, immunophenotyping, cytogenetics, and molecular biology studies in order to arrive at an accurate diagnosis and prognosis and to guide treatment choices.

11.
Mol Biol Cell ; 12(5): 1315-28, 2001 May.
Artigo em Inglês | MEDLINE | ID: mdl-11359924

RESUMO

A "spindle assembly" checkpoint has been described that arrests cells in G1 following inappropriate exit from mitosis in the presence of microtubule inhibitors. We have here addressed the question of whether the resulting tetraploid state itself, rather than failure of spindle function or induction of spindle damage, acts as a checkpoint to arrest cells in G1. Dihydrocytochalasin B induces cleavage failure in cells where spindle function and chromatid segregation are both normal. Notably, we show here that nontransformed REF-52 cells arrest indefinitely in tetraploid G1 following cleavage failure. The spindle assembly checkpoint and the tetraploidization checkpoint that we describe here are likely to be equivalent. Both involve arrest in G1 with inactive cdk2 kinase, hypophosphorylated retinoblastoma protein, and elevated levels of p21(WAF1) and cyclin E. Furthermore, both require p53. We show that failure to arrest in G1 following tetraploidization rapidly results in aneuploidy. Similar tetraploid G1 arrest results have been obtained with mouse NIH3T3 and human IMR-90 cells. Thus, we propose that a general checkpoint control acts in G1 to recognize tetraploid cells and induce their arrest and thereby prevents the propagation of errors of late mitosis and the generation of aneuploidy. As such, the tetraploidy checkpoint may be a critical activity of p53 in its role of ensuring genomic integrity.


Assuntos
Quinases relacionadas a CDC2 e CDC28 , Divisão Celular , Citocalasina B/farmacologia , Fase G1 , Poliploidia , Fuso Acromático/metabolismo , Proteína Supressora de Tumor p53/metabolismo , Actinas/antagonistas & inibidores , Actinas/metabolismo , Animais , Divisão Celular/efeitos dos fármacos , Linhagem Celular , Separação Celular , Cromossomos/metabolismo , Quinase 2 Dependente de Ciclina , Inibidor de Quinase Dependente de Ciclina p21 , Quinases Ciclina-Dependentes/metabolismo , Ciclinas/metabolismo , Citocalasina B/análogos & derivados , Inibidores Enzimáticos/metabolismo , Citometria de Fluxo , Humanos , Immunoblotting , Camundongos , Proteínas Serina-Treonina Quinases/metabolismo , Ratos , Tubulina (Proteína)/metabolismo
12.
J Radiol ; 87(6 Pt 1): 619-38, 2006 Jun.
Artigo em Francês | MEDLINE | ID: mdl-16788536

RESUMO

The development of new imaging modalities such as computed tomography and magnetic resonance imaging is a new phenomenon in thanatology. The growing accessibility to these technologies allows, under some conditions, the acquisition of cross-sectional images on cadavers. The authors present a practical pictorial review of post-mortem changes and deadly injuries, illustrating the contributions of modern cross-sectional imaging techniques in thanatology.


Assuntos
Imageamento por Ressonância Magnética , Mudanças Depois da Morte , Tomografia Computadorizada por Raios X , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Causas de Morte , Criança , Pré-Escolar , Feminino , Humanos , Lactente , Recém-Nascido , Masculino , Pessoa de Meia-Idade
13.
Cancer Res ; 61(20): 7660-8, 2001 Oct 15.
Artigo em Inglês | MEDLINE | ID: mdl-11606409

RESUMO

p21WAF1 and 14-3-3sigma, which are both transcriptional products of p53, have been reported to play a role in the G2 DNA damage checkpoint in mammalian cells. Human colon carcinoma cells, isogenic except for the presence or absence of either p21WAF1 or 14-3-3sigma (T. A. Chan et al., Genes Dev., 14: 1584-1588, 2000), are useful models for analysis of the role of these proteins in checkpoint control. Here, we have examined mitotic behavior within a single cell cycle after DNA damage in these cell lines. Our results show that p21WAF1, but not 14-3-3sigma, imposes a significant G2 delay after DNA damage. After G2 delay, we found that all isogenic cells, including those competent for both p21WAF1 and 14-3-3sigma, adapt to the DNA damage checkpoint and progress into mitosis, where they undergo incomplete chromosome segregation and reenter G1 with a tetraploid DNA content. Strikingly, our results show that p21WAF1, but not 14-3-3sigma, activates a checkpoint in response to DNA damage that prevents continued cycling of the tetraploid cells that result from a mitotic catastrophe characterized by failure to complete cell division. These results demonstrate that a tetraploid DNA content is not a reliable criterion to establish that arrest occurs in G2. Also, the DNA damage checkpoint mediated by p53-dependent induction of p21WAF1 assures neither G2 arrest nor DNA repair sufficient to enable accurate chromosome segregation in human colon carcinoma cells. We conclude that p21WAF1, but not 14-3-3sigma, has a unique role in the induction of G1 arrest in tetraploid cells that results from mitotic catastrophe after DNA damage.


Assuntos
Biomarcadores Tumorais , Neoplasias do Colo/genética , Neoplasias do Colo/patologia , Ciclinas/fisiologia , Dano ao DNA , Exonucleases , Fase G2/fisiologia , Proteínas de Neoplasias , Proteínas/fisiologia , Proteínas 14-3-3 , Antineoplásicos/farmacologia , Inibidor de Quinase Dependente de Ciclina p21 , DNA de Neoplasias/efeitos dos fármacos , DNA de Neoplasias/genética , DNA de Neoplasias/efeitos da radiação , Doxorrubicina/farmacologia , Etoposídeo/farmacologia , Exorribonucleases , Fase G2/genética , Humanos , Microscopia Confocal , Mitose/efeitos dos fármacos , Mitose/fisiologia , Mitose/efeitos da radiação , Índice Mitótico , Nocodazol/farmacologia , Ploidias , Células Tumorais Cultivadas
14.
Biochim Biophys Acta ; 1368(2): 276-88, 1998 Jan 19.
Artigo em Inglês | MEDLINE | ID: mdl-9459605

RESUMO

Most of the cationic lipids used for gene transfer experiments drastically lose their efficiency in the presence of serum. We used a cationic lipid with a spermine head group and its fluorescent analog to study the cellular uptake and the intracellular fate of lipoplexes in the presence and absence of serum. We found that the amount of DNA and lipid taken up by the cells was not related to the efficacy of the gene transfer. When the lipofection was performed in the presence of serum, lipoplexes were contained within small intracellular vesicles. In the absence of serum, the vesicles were larger and heterogeneous in size and shape. By analysis of their size distribution, we showed that lipoplexes preformed in the absence of serum tended to aggregate. This aggregation was inhibited in the presence of serum. We used a carbonate formulation that led to the preformation of large particles: those large particles gave a high lipofection efficiency in the presence of serum and their intracellular distribution was identical to that observed in the absence of serum.


Assuntos
Lipídeos , Plasmídeos/genética , Transfecção/métodos , Células 3T3 , Animais , Sangue , Cátions , Linhagem Celular , Citoplasma/química , Fibroblastos , Corantes Fluorescentes , Camundongos , Plasmídeos/análise , Plasmídeos/metabolismo , Rodaminas , Espermina/química
15.
J Clin Oncol ; 6(6): 976-82, 1988 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-2897433

RESUMO

From February 1983 to January 1985, 497 patients with advanced breast cancer were randomly allocated to receive either epirubicin or doxorubicin in the following combination chemotherapy regimen: fluorouracil (5-FU) 500 mg/m2 intravenous (IV) on days 1 and 8; epirubicin or doxorubicin 50 mg/m2 IV on day 1; cyclophosphamide 500 mg/m2 IV on day 1 (FEC or FAC). Cycles were repeated every 21 days until progression or to cumulative doses of 700 mg/m2 for epirubicin and 550 mg/m2 for doxorubicin. Dose reductions were applied according to the standard criteria. Activity was evaluated in 443 patients (222 in the FEC arm and 221 in the FAC arm). The two experimental groups were comparable in age, performance status, menopausal status, histology, previous treatments, and site of the disease. The overall response rate (complete response and partial response [CR + PR]) was not significantly different: 53.6% for FEC and 56.5% for FAC. The median time to progression was 273 days for FEC and 314 days for FAC; the median survival time was 591 and 613 days, respectively. Leukopenia, anemia, nausea, and vomiting were significantly lower in patients treated with FEC. As for cardiotoxicity, four cases of congestive heart failure (CHF) were recorded among patients treated with FAC while only one was observed in the FEC group. These results indicate that epirubicin in a combination chemotherapy regimen is as active as doxorubicin and is significantly less toxic.


Assuntos
Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico , Neoplasias da Mama/tratamento farmacológico , Adulto , Idoso , Protocolos de Quimioterapia Combinada Antineoplásica/efeitos adversos , Ensaios Clínicos como Assunto , Ciclofosfamida/efeitos adversos , Ciclofosfamida/uso terapêutico , Doxorrubicina/efeitos adversos , Doxorrubicina/uso terapêutico , Epirubicina , Feminino , Fluoruracila/efeitos adversos , Fluoruracila/uso terapêutico , Coração/efeitos dos fármacos , Humanos , Pessoa de Meia-Idade , Distribuição Aleatória
16.
J Neuroradiol ; 32(4): 278-80, 2005 Sep.
Artigo em Francês | MEDLINE | ID: mdl-16237368

RESUMO

Paraneoplastic limbic encephalitis is a rare clinical entity, most often associated with small cell lung cancer. We report a case of a 54-year-old man presenting status epilepticus, cognitive dysfunction and loss of short term memory associated with epidermoid lung carcinoma. CT scan was normal whereas MRI revealed hyperintensities on T2WI and FLAIR images in the temporolimbic regions. Treatment of the primary tumour was followed by neurological improvement.


Assuntos
Carcinoma de Células Escamosas/complicações , Encefalite Límbica/etiologia , Neoplasias Pulmonares/complicações , Humanos , Masculino , Pessoa de Meia-Idade
17.
J Radiol ; 86(9 Pt 2): 1091-101, 2005 Sep.
Artigo em Francês | MEDLINE | ID: mdl-16227905

RESUMO

Imaging of stroke has evolved with the development of stroke units and the CE approval of intravenous thrombolysis in the first three hours after stroke onset. The goal of imaging in the acute phase of stroke is: to make the diagnosis of stroke; to rule out other diagnosis (above all hemorrhagic strokes); to precise the location of the arterial occlusion; to assess the level of hypoperfusion; to evaluate the viability and reversibility of brain lesions; to understand the origin of the stroke by evaluating cervical arteries. Constraints of imaging in the acute phase of stroke are: the need to be performed as fast as possible to not delay IV thrombolysis (time is brain); machines must be available 24 hours a day, 7 days a week as close as possible to the stroke unit. The aim of imaging are: in routine practice to evaluate the likely benefits (provided by penumbra imaging) and risks of IV thrombolysis; in term of "evidence based medicine" to better evaluate new specific stroke therapies in randomized studies (IV thrombolysis between 3 to 4 hours, use of anti GpIIbIIIa, intra-arterial mechanical or chemical thrombolysis...). Magnetic resonance imaging is considered the goal standard of stroke imaging allowing to evaluate in a "one stop shopping" the level of arterial occlusion, hypoperfusion and brain viability. However, stroke management is a regional issue and performing MR in extreme emergency is almost impossible in all stroke units outside or even within university hospitals 24 hours a day. CT-perfusion and CT angiography are therefore an accurate alternative tool for acute stroke imaging. Multislice CT is indeed available in almost all stroke units. The examination is very time-saving and clinically relevant to make the decision for IV thrombolysis.


Assuntos
Isquemia Encefálica/diagnóstico por imagem , Tomografia Computadorizada por Raios X/métodos , Adulto , Idoso , Isquemia Encefálica/tratamento farmacológico , Angiografia Cerebral/métodos , Infarto Cerebral/diagnóstico por imagem , Infarto Cerebral/tratamento farmacológico , Circulação Cerebrovascular/fisiologia , Tomada de Decisões , Feminino , Fibrinolíticos/uso terapêutico , Humanos , Processamento de Imagem Assistida por Computador/métodos , Masculino , Complexo Glicoproteico GPIIb-IIIa de Plaquetas/uso terapêutico , Fatores de Risco , Terapia Trombolítica , Fatores de Tempo , Sobrevivência de Tecidos/fisiologia , Resultado do Tratamento
18.
Cancer Gene Ther ; 7(5): 789-98, 2000 May.
Artigo em Inglês | MEDLINE | ID: mdl-10830726

RESUMO

Recently, a new p53 derivative has been designed, namely chimeric tumor suppressor 1 (CTS1), in which the p53 domains that are known to mediate p53 inactivation have been replaced. In this study, the antitumoral activity of CTS1 mediated by adenovirus vector has been evaluated in comparison with a p53 adenovirus vector in various human tumor cell lines. In vitro, in terms of cell growth inhibition, the CTS1 vector was significantly (P < .01) more efficient (2- to 7-fold) than the p53 vector in tumor models overexpressing an inhibitor of p53, murine double minute-2. This result was confirmed in vivo in a pre-established tumor developed in nude mice. In an osteosarcoma model overexpressing murine double minute-2, we have shown a significantly (P < .05) higher tumor growth delay with the CTS1 vector compared with the p53 vector (25.6 days compared with 12.4 days). Furthermore, both in vitro and in vivo, we have shown that this higher inhibition of tumor growth with the CTS1 vector was correlated with a higher induction of apoptosis. Therefore, CTS1 is a potentially improved tumor suppressor gene for the treatment of human tumors resistant to wild-type p53 gene therapy.


Assuntos
Genes p53/genética , Terapia Genética/métodos , Neoplasias Experimentais/terapia , Proteínas Nucleares , Proteínas Proto-Oncogênicas/metabolismo , Adenoviridae/genética , Animais , Apoptose/efeitos dos fármacos , Neoplasias da Mama/terapia , Ciclo Celular/efeitos dos fármacos , Divisão Celular/efeitos dos fármacos , Citometria de Fluxo , Técnicas de Transferência de Genes , Humanos , Imuno-Histoquímica , Marcação In Situ das Extremidades Cortadas , Neoplasias Pulmonares/terapia , Camundongos , Camundongos Nus , Transplante de Neoplasias , Osteossarcoma/terapia , Proteínas Proto-Oncogênicas c-mdm2 , Fatores de Tempo , Células Tumorais Cultivadas
19.
Radiother Oncol ; 47(1): 91-8, 1998 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-9632299

RESUMO

PURPOSE: We present a comparative planning of different approaches for external radiotherapy in age-related maculopathies. MATERIALS AND METHODS: Calculated dose distributions and dose-volume histograms for (a) bilateral irradiation with 6 MV photons, (b) a single lateral-oblique beam using either photons, electrons or protons and (c) an anterior circular proton beam. RESULTS: For lateral photon or electron beams the dose to the lens is usually lower than 10% of the dose to the macula. The entrance doses for bilateral photon beams are about 50% which increase up to 100% at the orbital bone. About 5 mm of optic nerves are irradiated at the maximal dose while the optic chiasma is spared. A single photon beam gives 50% of the dose to the fellow eye. The electron beam spares the fellow eye but gives a rather inhomogeneous dose to the target volume. For a lateral proton beam, 4 mm of optic nerve receives 90% of the dose, the skin dose is at least 70% of the dose to the macula and the lens and the fellow eye are spared. An anterior proton beam gives 90% of the dose to 1 mm of optic nerve and the 50% isodose approaches the periphery of the lens. CONCLUSION: Doses to the critical structures can be dramatically diminished for all the techniques by reducing the beam size, but only if very precise set-up techniques are used. Proton beams are an attractive solution, but the impact of such a choice on the use of proton facilities and on the national health system should be carefully evaluated, as well as the risk of radio-induced secondary neoplasias.


Assuntos
Degeneração Macular/radioterapia , Planejamento da Radioterapia Assistida por Computador , Humanos , Macula Lutea/diagnóstico por imagem , Macula Lutea/efeitos da radiação , Degeneração Macular/diagnóstico por imagem , Quiasma Óptico/diagnóstico por imagem , Quiasma Óptico/efeitos da radiação , Nervo Óptico/diagnóstico por imagem , Nervo Óptico/efeitos da radiação , Doses de Radiação , Proteção Radiológica/instrumentação , Tomografia Computadorizada por Raios X
20.
Res Microbiol ; 146(8): 659-70, 1995 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-8584789

RESUMO

Salmonella typhimurium is a ubiquitous pathogenic bacterium able to sustain the environmental conditions of the gastrointestinal tract, including biliary salts. To understand the mechanisms involved in bile salt resistance and, more generally, detergent resistance, we investigated S. typhimurium mutants produced with the random mutagenic TnphoA transposon. A total of 3,000 transpositional mutants were isolated. Three strains among the 1,432 first mutants lost the ability to grow in the presence of biological and chemical detergents. They were prototrophic and exhibited normal lipopolysaccharide and outer membrane protein profiles after SDS-PAGE. They did not show sensitivity to dyes but showed very different sensitivities to antibiotics. For each mutant strain, Southern blotting analysis revealed a unique TnphoA insertion at different chromosomal locations. These observations were confirmed by transduction experiments.


Assuntos
Antibacterianos/farmacologia , Ácidos e Sais Biliares/farmacologia , Elementos de DNA Transponíveis/genética , Detergentes/farmacologia , Salmonella typhimurium/efeitos dos fármacos , Proteínas da Membrana Bacteriana Externa/análise , Southern Blotting , DNA Bacteriano/química , Resistência Microbiana a Medicamentos , Técnicas In Vitro , Lipopolissacarídeos/biossíntese , Mutagênese Insercional , Salmonella typhimurium/genética , Salmonella typhimurium/crescimento & desenvolvimento , Salmonella typhimurium/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA